Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas

British Journal of Dermatology

Volumn 143, Issue 6, 2000, Pages 1205-1210

  Dereure, O ^a   Portales, P ^a   Clot, J ^a   Guilhou, J J ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Apoptosis; CD95; Cutaneous T cell lymphoma; Fas

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; FAS ANTIGEN; STEROID;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0034522369     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03889.x     Document Type: Article

References (32)

1. A unique cellular type of skin-associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by the benign and malignant T cells at cutaneous sites
2. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides
3. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients
4. HTLV-I, CTCL: The link is missing
5. No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma
6. Mycosis fungoides and Sézary syndrome are not associated with HTLV-I infection: An international study
7. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: A study of 64 patients
8. Absence of Epstein-Barr viral encoded RNA (EBER) in primary cutaneous T-cell lymphoma
9. Lymphocyte activation in cutaneous T-cell lymphoma
10. The changing survival of patients with mycosis fungoides: A population-based assessment of trends in United States
11. Molecular insights into the immunopathogenesis of follicular lymphoma
12. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas
13. The Fas death factor
14. Apoptosis by death factor
15. Fas and Fas ligand, in the homeostatic regulation of immune responses
16. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation
17. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95)
18. Mutations in the Fas antigen in patients with multiple myeloma
19. Somatic fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
20. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia
21. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells
22. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
23. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
24. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative syndrome associated with autoimmunity
25. Missense mutations in the fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
26. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis
27. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma
28. Immunophenotyping of the T lymphocytes by three-color flow cytometry in healthy newborns, children and adults
29. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome
30. An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand
31. Fas ligand in human serum
32. Elevated serum soluble Fas ligand in natural killer cell proliferative disorders